本分类收录的细胞产品与配套技术资料，支持按来源、物种与规格筛选。 共 293 个产品。
Human iPSC From Blood-Cerebral Creatine Deficiency Syndrome 2 provides patient-derived iPSCs for modeling metabolic and neurological disorders.
The Human iPSC From Blood-Cerebral Creatine Deficiency Syndrome 3 serves as the powerful tool for the modeling creatine metabolism disorders.
ABC-SC120G comes from a chromosome XP11.3 deletion syndrome donor. The parental cell line was recovered reprogrammed to an induced pluripotent stem cell line and expanded. The expanded line was evaluated for viability surface antigen expression and alkaline phosphatase activity. Pluripotency was assessed via embryoid body (EB) formation. Steady-state mRNA expression patterns of undifferentiated iPSC and EBs were determined via real-time PCR.
Human iPSC From Blood-Epileptic Encephalopathy offers patient-derived in vitro models for neuronal biology, disease mechanisms, and therapeutic discovery.
The Human iPSC From Blood-Helsmoortel-Van Der Aa Syndrome provides a patient-derived stem cell model for neurodevelopmental disorder studies.
Human iPSC From Blood-Isogenic Control, Nescav Syndrome offers a reliable disease model for studying Nescav pathology and therapeutic development.
Human iPSC From Blood-Mental Retardation offers a reprogrammed stem cell model for neurodevelopment, disease modeling, and functional genomics research.
Human iPSC From Blood-Multicentric Carpotarsal Osteolysis Syndrome provides a disease model for osteolysis studies and therapeutic screening.
The Human iPSC From Blood-Myopathy provides pluripotent stem cells for disease modeling, drug testing, and regenerative medicine applications.
Discover potential of human iPSC derived from blood in studying Nemaline Myopathy. Explore innovative research and therapeutic advancements in this field.
Human iPSC From Blood-NESCAV Syndrom ,Blood-derived iPSC line for studies on NESCAV syndrome, KIF1A mutation, neurodevelopment, and disease modeling.
Explore Human iPSC From Blood-Nescav Syndrome, High-quality iPSC line for modeling Nescav Syndrome and studying KIF1A function and genetic effects.
Human iPSC From Blood-Neurodevelopmental Disorder offers a pluripotent model to study neural development and disease-specific genetic mechanisms.
Human iPSC From Blood–Rigid Spine Muscular Dystrophy 1 provides an integration-free disease model for SEPN1-related myopathy and therapeutic testing.
This iPS cell line is derived from a Turner Syndrome donor's blood, reprogrammed using Sendai virus.
Human iPSC From Fibroblast-Alagille Syndrome 1 provides an in vitro model for studying genetic disorders and disease modeling in Alagille syndrome.
Human iPSC From Fibroblast-Alzheimer Disease provides patient-derived stem cells for modeling neurodegeneration and screening potential therapeutics.
Human iPSC From Fibroblast-Canavan Disease ,Patient-derived iPSCs for modeling Canavan disease, ASPA deficiency, and neurodegenerative mechanisms.
Enhance Human iPSC From Fibroblast-Ceroid Lipofuscinosis from ImmunoClone, a neuronal model enabling studies of CLN2 gene, late infantile type, and pathology.
Human iPSC From Fibroblast-Charcot-Marie-Tooth Disease provides patient-derived iPSCs for disease modeling, drug screening, and regenerative research.
Human iPSC From Fibroblast-Choroideremia serves as a disease-specific model for retinal degeneration, ideal for drug discovery and gene therapy research.
Uncover the significance of human iPSC from fibroblasts in Cockayne Syndrome Type A. Engage with pioneering research and explore new therapeutic pathways.
Human iPSC From Fibroblast-Developmental and Epileptic Encephalopathy 2 ,iPSC model with CDKL5 mutation for epilepsy and neurodevelopmental research.
Human iPSC From Fibroblast-Diabetes Mellitus, Juvenile-Onset Insulin-Dependent ,High-quality iPSC from juvenile insulin-dependent diabetes fibroblasts.
共 293 个产品 ｜ 第 10 / 13 页
